Clinical trial
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small…
NCT00006126 · Northwestern University, Other · Withdrawn
Key facts
| NCT number | NCT00006126 |
|---|---|
| Title | Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery |
| Official title | Allogeneic Peripheral Blood Progenitor Cell Transplantation in Patients With Incurable Solid Tumors: A Phase I Study |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Kidney Cancer, Lung Cancer, Melanoma (Skin), Testicular Germ Cell Tumor |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | busulfan, cyclophosphamide, etoposide, fludarabine phosphate, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 0 |
| Start date | Sep 1, 1999 |
| Primary completion | Apr 1, 2001 |
| Completion | Apr 1, 2001 |
| First posted | Mar 8, 2004 |
| Last update posted | Nov 13, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: